Eli Lilly
LLY
$732.20
Share price
-1.81%
Change (1 day)
91.00%
Change (1 year)
Categories
With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
P/S ratio for Eli Lilly (LLY)
P/S ratio as of April 2024 (TTM): 20.4
According to Eli Lilly's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 20.4006. At the end of 2023 the company had a P/S ratio of 16.2.
P/S ratio history for Eli Lilly from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 16.2 | 33.15% |
| 2022 | 12.2 | 30.53% |
| 2021 | 9.33 | 41.77% |
| 2020 | 6.58 | 16.73% |
| 2019 | 5.64 | 2.71% |
| 2018 | 5.49 | 35.01% |
| 2017 | 4.07 | 6.28% |
| 2016 | 3.83 | -18.01% |
| 2015 | 4.67 | 19.45% |
| 2014 | 3.91 | 58.51% |
| 2013 | 2.46 | -1.49% |
| 2012 | 2.50 | 26.27% |
| 2011 | 1.98 | 13.23% |
| 2010 | 1.75 | -6.89% |
| 2009 | 1.88 | -16.37% |
| 2008 | 2.25 | -30.87% |
| 2007 | 3.25 | -13.5% |
| 2006 | 3.76 | -13.95% |
| 2005 | 4.37 | -5.79% |
| 2004 | 4.64 | -26.2% |
| 2003 | 6.28 | -2.38% |
| 2002 | 6.43 | -15.82% |
| 2001 | 7.64 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.85 | -81.14% | 🇺🇸 USA |
 Novartis NVS | 3.94 | -80.67% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.54 | -87.53% | 🇺🇸 USA |
 AbbVie ABBV | 5.47 | -73.19% | 🇺🇸 USA |
 Amgen AMGN | 5.19 | -74.54% | 🇺🇸 USA |
 Sanofi SNY | 2.31 | -88.67% | 🇫🇷 France |
 Merck MRK | 5.35 | -73.77% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2.20 | -89.21% | 🇺🇸 USA |
 AstraZeneca AZN | 4.82 | -76.38% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2.21 | -89.19% | 🇬🇧 UK |